Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

Transplantation
D PrzepiorkaM Korbling

Abstract

We have evaluated the use of blood stem cell grafts for rapid hematopoietic recovery and tacrolimus (FK506) as GVHD prophylaxis to reduce early mortality after allogeneic transplantation. Eighty-five adults with advanced leukemia received high-dose thiotepa, busulfan, and cyclophosphamide as a preparative regimen in a prospective Phase II study. All donors were HLA-matched and related. Marrow (BMT) was used for 44 patients and filgrastim-mobilized blood stem cells (SCT) for 41 patients. GVHD prophylaxis consisted of cyclosporine (CsA) or FK506 with methotrexate (MTX) or methylprednisolone (MP). The median time to neutrophil recovery was earlier after SCT than after BMT (day 10 vs. 17, P<0.001), but this was due to the selective use of MTX only in the BMT patients. The risk of grades 2-4 GVHD was lower with FK506 than with CsA (16% vs. 45%, P=0.02) and was the same for SCT recipients as for BMT recipients (33% vs. 34%). Regimen-related toxicity was significantly lower after SCT than after BMT but did not differ between the FK506 and CsA patients. In comparison with those receiving the standard transplant (BMT with CsA and MTX), only the SCT recipients using FK506 and MP had a significantly higher survival at day 180 posttranspla...Continue Reading

Citations

Aug 5, 2000·The Annals of Pharmacotherapy·T J Lee, L A Kennedy
Jul 27, 2004·Bone Marrow Transplantation·M A DiazUNKNOWN Spanish Group for Allogeneic Peripheral Blood Transplantation
Sep 10, 1998·American Journal of Respiratory and Critical Care Medicine·K J PriceB S Andersson
Apr 13, 2000·Cancer Control : Journal of the Moffitt Cancer Center·S J Noga, P V O'Donnell
Jun 24, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kara Fortune, Daniel Couriel
Sep 12, 2000·Bone Marrow Transplantation·K van BesienR Hoffman
Apr 14, 2006·Expert Opinion on Biological Therapy·Michael Y ShapiraShimon Slavin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.